Influenza Vaccine Market to Reach $17.41 Billion by 2035, Growing at 7.72% CAGR | Sanofi, GSK, Pfizer Lead Global Competition
· roots analysis
AI Briefing
- The global influenza vaccine market is expected to reach $17.41 billion by 2035, growing at a 7.72% CAGR.
- Sanofi, GlaxoSmithKline (GSK), and Pfizer are leading the global competition.
- Seasonal flu infects roughly 5-10% of the global population each year.
Advertisement